pI: 11.6104 |
Length (AA): 151 |
MW (Da): 17446 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
65 | 148 | 1g1x (B) | 1 | 86 | 18.00 | 0 | 0.3 | 0.79 | -1.06 |
2 | 151 | 4kzy (N) | 2 | 151 | 64.00 | 0 | 1 | 1.76438 | -0.39 |
63 | 132 | 2vqe (O) | 4 | 73 | 21.00 | 0 | 0.37 | 0.764076 | -0.68 |
65 | 140 | 2vqe (O) | 2 | 79 | 20.00 | 0.00000003 | 0.24 | 0.715311 | -0.76 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127089)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G00100 | 40S ribosomal protein S13-2 |
Arabidopsis thaliana | AT3G60770 | 40S ribosomal protein S13-1 |
Babesia bovis | BBOV_I003470 | 40S ribosomal protein S13, putative |
Brugia malayi | Bm1_18940 | 40S ribosomal protein S13 |
Caenorhabditis elegans | CELE_C16A3.9 | Protein RPS-13 |
Cryptosporidium hominis | Chro.50159 | 40S ribosomal protein S13 |
Cryptosporidium parvum | cgd5_2210 | 40S ribosomal protein S13 |
Dictyostelium discoideum | DDB_G0284533 | 40S ribosomal protein S13 |
Drosophila melanogaster | Dmel_CG13389 | Ribosomal protein S13 |
Echinococcus granulosus | EgrG_000856900 | 40S ribosomal protein S13 |
Entamoeba histolytica | EHI_035460 | 40S ribosomal protein S13, putative |
Entamoeba histolytica | EHI_112880 | 40S ribosomal protein S13, putative |
Echinococcus multilocularis | EmuJ_000856900 | 40S ribosomal protein S13 |
Giardia lamblia | GL50803_16652 | Ribosomal protein S13 |
Homo sapiens | ENSG00000110700 | ribosomal protein S13 |
Leishmania braziliensis | LbrM.19.0710 | 40S ribosomal protein S13, putative |
Leishmania braziliensis | LbrM.33.3420 | 40S ribosomal protein S13, putative |
Leishmania donovani | LdBPK_333300.1 | 40S ribosomal protein S13, putative |
Leishmania infantum | LinJ.19.0390 | 40S ribosomal protein S13, putative |
Leishmania infantum | LinJ.33.3300 | 40S ribosomal protein S13, putative |
Leishmania major | LmjF.33.3150 | 40S ribosomal protein S13, putative |
Leishmania major | LmjF.19.0390 | 40S ribosomal protein S13, putative |
Leishmania mexicana | LmxM.19.0390 | 40S ribosomal protein S13, putative |
Leishmania mexicana | LmxM.32.3150 | 40S ribosomal protein S13, putative |
Loa Loa (eye worm) | LOAG_02817 | ribosomal protein S13 |
Mus musculus | ENSMUSG00000090862 | ribosomal protein S13 |
Mus musculus | 102642137 | 40S ribosomal protein S13-like |
Mus musculus | 100043695 | predicted gene 15483 |
Neospora caninum | NCLIV_036280 | 30S ribosomal protein S15P/S13e, related |
Oryza sativa | 4344524 | Os08g0117300 |
Oryza sativa | 4344523 | Os08g0117200 |
Plasmodium berghei | PBANKA_1135100 | 40S ribosomal protein S15, putative |
Plasmodium falciparum | PF3D7_1358800 | 40S ribosomal protein S15 |
Plasmodium knowlesi | PKNH_1112500 | 40S ribosomal protein S15, putative |
Plasmodium vivax | PVX_114910 | 40S ribosomal protein S15, putative |
Plasmodium yoelii | PY03929 | ribosomal protein S15, putative |
Saccharomyces cerevisiae | YDR064W | ribosomal 40S subunit protein S13 |
Schistosoma japonicum | Sjp_0213300 | ko:K02953 small subunit ribosomal protein S13e, putative |
Schistosoma mansoni | Smp_096750 | hypothetical protein |
Schmidtea mediterranea | mk4.008065.00 | |
Schmidtea mediterranea | mk4.004692.00 | |
Trypanosoma brucei gambiense | Tbg.972.2.4160 | 40S ribosomal protein S13, putative |
Trypanosoma brucei gambiense | Tbg972.10.18410 | 40S ribosomal protein S13, putative |
Trypanosoma brucei | Tb927.10.15120 | 40S ribosomal protein S13, putative |
Trypanosoma brucei | Tb927.2.5910 | 40S ribosomal protein S13, putative |
Trypanosoma congolense | TcIL3000_10_12920 | 40S ribosomal protein S13, putative |
Trypanosoma congolense | TcIL3000_0_44580 | 40S ribosomal protein S13, putative |
Trypanosoma congolense | TcIL3000_2_1570 | 40S ribosomal protein S13, putative |
Trypanosoma cruzi | TcCLB.510973.30 | 40S ribosomal protein S13, putative |
Trypanosoma cruzi | TcCLB.510029.70 | 40S ribosomal protein S13, putative |
Trypanosoma cruzi | TcCLB.511189.30 | 40S ribosomal protein S13, putative |
Trypanosoma cruzi | TcCLB.511291.90 | 40S ribosomal protein S13, putative |
Toxoplasma gondii | TGME49_270380 | ribosomal protein RPS13 |
Theileria parva | TP01_0502 | 40S ribosomal protein S13, putative |
Trichomonas vaginalis | TVAG_076150 | ribosomal protein S15p/S13e, putative |
Trichomonas vaginalis | TVAG_259930 | 30S ribosomal protein S15p/S13e, putative |
Trichomonas vaginalis | TVAG_066760 | ribosomal protein S15p/S13e, putative |
Trichomonas vaginalis | TVAG_151780 | 30S ribosomal protein S15p/S13e, putative |
Trichomonas vaginalis | TVAG_138940 | 30S ribosomal protein S15p/S13e, putative |
Trichomonas vaginalis | TVAG_324920 | ribosomal protein S15p/S13e, putative |
Trichomonas vaginalis | TVAG_459150 | ribosomal protein S15p/S13e, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.2.5910 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.2.5910 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.2.5910 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.2.5910 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.10.15120 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.15120 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.15120 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.15120 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C16A3.9 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C16A3.9 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C16A3.9 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C16A3.9 | Caenorhabditis elegans | sterile | wormbase |
YDR064W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1135100 | Plasmodium berghei | Essential | plasmo |
TGME49_270380 | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.